February 13th, 2015
Can Clopidogrel Get Along with Proton Pump Inhibitors?
CardioExchange Editors, Staff
Are there clinically significant interactions between clopidogrel, proton pump inhibitors, and other drugs?
May 18th, 2014
Statins Disappoint In COPD And ARDS
Larry Husten, PHD
Two NHLBI studies have failed to find any benefit for statin therapy in patients with chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS). Previous observational studies had raised the possibility that statins, perhaps due to their anti-inflammatory effects, might improve outcomes in people with these serious diseases. But both trials were stopped early by […]
December 10th, 2013
Co-Chairs of CVD Risk Guidelines Discuss a Difficult Case
Eric Lindley, MD, Donald M Lloyd-Jones, MD, ScM and David C. Goff, Jr., MD, PhD
Fellow Eric Lindley presents a challenging case to David Goff and Donald Lloyd-Jones, co-chairs of the new 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk.
July 22nd, 2010
HDL and Residual Risk: A Surprising Finding in JUPITER
Larry Husten, PHD
CardioExchange welcomes Dr. Paul Ridker to answer questions about his recent paper in the Lancet, which analyzed data from JUPITER and found that HDL may not predict residual risk in patients on high-dose statins who reach very low LDL levels such as those achieved in the treatment group in JUPITER. The findings may surprise some readers, though […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy